3.90Open3.90Pre Close0 Volume3.20K Open Interest20.00Strike Price0.00Turnover80.95%IV15.22%PremiumJan 17, 2025Expiry Date1.01Intrinsic Value100Multiplier75DDays to Expiry2.89Extrinsic Value100Contract SizeAmericanOptions Type-0.4756Delta0.0576Gamma5.80Leverage Ratio-0.0173Theta-0.0212Rho-2.76Eff Leverage0.0343Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet